Coloplast A/S (CLPBF)
62.30
0.00 (0.00%)
USD |
OTCM |
Sep 17, 16:00
Coloplast Price to Book Value : 6.867 for Sept. 17, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 6.867 |
| September 16, 2026 | 6.867 |
| September 15, 2026 | 7.532 |
| September 14, 2026 | 7.532 |
| September 11, 2026 | 7.532 |
| September 10, 2026 | 7.532 |
| September 09, 2026 | 7.532 |
| September 08, 2026 | 7.532 |
| September 04, 2026 | 7.532 |
| September 03, 2026 | 7.532 |
| September 02, 2026 | 7.532 |
| September 01, 2026 | 7.532 |
| August 31, 2026 | 7.532 |
| August 28, 2026 | 7.532 |
| August 27, 2026 | 7.532 |
| August 26, 2026 | 7.532 |
| August 25, 2026 | 7.532 |
| August 24, 2026 | 7.532 |
| August 21, 2026 | 7.532 |
| August 20, 2026 | 7.532 |
| August 19, 2026 | 7.306 |
| August 18, 2026 | 7.306 |
| August 17, 2026 | 7.190 |
| August 14, 2026 | 7.167 |
| August 13, 2026 | 7.167 |
| Date | Value |
|---|---|
| August 12, 2026 | 7.167 |
| August 11, 2026 | 7.425 |
| August 10, 2026 | 7.197 |
| August 07, 2026 | 7.197 |
| August 06, 2026 | 7.197 |
| August 05, 2026 | 7.197 |
| August 04, 2026 | 7.249 |
| August 03, 2026 | 7.249 |
| July 31, 2026 | 7.249 |
| July 30, 2026 | 7.249 |
| July 29, 2026 | 7.135 |
| July 28, 2026 | 7.165 |
| July 27, 2026 | 7.055 |
| July 24, 2026 | 7.055 |
| July 23, 2026 | 7.055 |
| July 22, 2026 | 7.055 |
| July 21, 2026 | 7.055 |
| July 20, 2026 | 6.620 |
| July 17, 2026 | 6.620 |
| July 16, 2026 | 6.620 |
| July 15, 2026 | 6.620 |
| July 14, 2026 | 6.620 |
| July 13, 2026 | 6.808 |
| July 10, 2026 | 6.808 |
| July 09, 2026 | 6.808 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ambu A/S | 2.825 |
| Abbott Laboratories | 3.482 |
| AngioDynamics, Inc. | 3.718 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 5.819 |
Price to Book Value Related Metrics
| PE Ratio | 32.64 |
| PS Ratio | 3.162 |
| Price to Free Cash Flow | 14.47 |
| Price | 62.30 |
| Earnings Yield | 3.06% |
| Market Cap | 14.04B |
| Operating PE Ratio | 12.05 |
| Normalized PE Ratio | 18.08 |